Recursion Pharmaceuticals (RXRX) Bank of America SMID Cap Virtual Conference summary

Conference overview

• The event featured presentations from nearly 20 small and mid-cap companies, with a focus on innovation and financial performance across sectors.

• Analysts highlighted continued leadership and growth expectations for mid-cap companies in the latter half of the year.

• Sessions included in-depth fireside chats, Q&A, and strategic discussions with company executives.

Company strategy and leadership transition

• Upstart's new CEO emphasized a shift to the "second leg of the race," focusing on operational efficiency and profitability.

• The company streamlined priorities to drive contribution profit and capital efficiency, especially in core personal loans.

• Leadership is balancing short-term profitability with long-term market expansion, aiming for sustainable compounding growth.

Financial performance and growth drivers

• Upstart achieved record contribution profits in Q2 2026, surpassing previous highs despite tougher macro conditions.

• Core personal loans grew 27% sequentially, driven by management focus and improved funnel efficiency.

• Home and auto products saw a 61 percentage point improvement in contribution margin, with a focus on unit economics over growth.